Navigation Links
Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting
Date:10/29/2007

e world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively and with sub-millimeter accuracy. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver precise, high-dose radiation, minimizing damage to surrounding healthy tissue and eliminating the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 35,000 patients worldwide and currently more than 100 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release regarding procedure growth and market acceptance, clinical studies, regulatory review and approval, and commercial
'/>"/>

SOURCE Accuray Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...r some pediatric cancers, particularly Ewing sarco...rding to a new study published online December 4 i..., This study was undertaken because there is lim...d up to 20 years) for pediatric cancer patients. ,...cer Center and Blood Disorders Service, Children,s...
(Date:12/4/2009)...cans are recruited annually to participate in clin...search Protection (AHRP), and most will be compens...titutions view payments to volunteers as compensat... potential risks related to participating in the e... have a very different view of clinical trial comp...
(Date:12/4/2009)... fruit consumption leads to success, study finds ... Increased exercise, reduced soda consumption and ...control strategies for adolescents, a new study sh...ut their weight-control strategies and lifestyle h...d 68 had not. The responses were grouped into four...
(Date:12/4/2009)...d for at-risk patient groups , , FRIDAY,..., particularly Ewing sarcomas and central nervous ...U.S. researchers have found. , The study author... the most common pediatric cancers who were enroll...e researchers found that the overall cancer recurr...
(Date:12/4/2009)... many hesitate to take breast cancer drug, study f... -- Worries about side effects are a major reason ...for breast cancer are willing to take the drug tam..., In an effort to inform women about the risks ...ersity of Michigan Comprehensive Cancer Center cre...
Breaking Medicine News(10 mins):Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2
...r Martin Watterson and team from Northwestern Univ...ew compound called MW01-5-188WH which has been fou... Cytokines which leads to activation of glia, whic...lzheimer’s disease is characterized by loss in mem...
...ria parasites can develop in the lymph nodes also,...ard. This reportedly has implications for the mamm...se is caused when a mosquito infected with Plasmod...s and infect red blood cells, beginning the onset ...
...published in the Journal of Infectious Diseases ha...f Staphylococcus aureus in nasal samples, // among...ive factor in a majority of the hospital acquired ...n the US. About 1% of the nasal samples test...
...r Rosemary Crompton conducted a survey in 5 Europe...ween work life and domestic life // to find out w... would like to have a traditional life style, the ... Researchers found that women who worked hard...
...n who underwent the world’s first face transplant ...hospital. Doctors say that she is increasing the r... Isabelle Dinoire, 38, hailing from France was...e donor of the face was a 46-year old teacher who ...
...k antibiotic drug which is used for treating lung ... failure, according to a report. //Medical practit...aid that they found three cases of liver failure i...f each other last year, said report co-author John...
Other Medicine News:Health News:Malaria Can Develop In Lymph Nodes Also 2Health News:90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose 2
(Date:12/4/2009)...ire-FirstCall/ -- Vermillion, Inc. (VRML) (Pink Sh...t filed its First Amended Plan of Reorganization a...nited States Bankruptcy Court for the District of ...cy of the Disclosure Statement is presently schedu...confirmation of the Plan scheduled for January 7, ...
(Date:12/4/2009)...Newswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. ... an investor teleconference and webcast. Principa...s surrounding carfilzomib in relapsed and/or refra...erican Society of Hematology (ASH) Annual Meeting....CT/10:00 a.m. ET on Monday, December 7, 2009. The...
(Date:12/4/2009)...wire/ -- Shared Imaging, LLC, an independent provi...rams for hospitals and healthcare providers, is ex...sion,s Accreditation for Ambulatory Health Care, a...pproval for quality and safety in patient care. Sh...mobile MRI and PET/CT services. Mobile services cl...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 21 in 4 nursing home residents carry MRSA 47915 11 in 4 nursing home residents carry MRSA 47915 2Engineered pig stem cells bridge the mouse human gap 8715 1Safe Playground to be Built at Politz Hebrew Academy 47914 1Safe Playground to be Built at Politz Hebrew Academy 47914 2
...he University of Nottingham in the British Midland... Cancer Patients, CHICAGO, Oct. 25 Today the Bri...at new research from The University of Nottingham,...r lung cancer. The study, published in the journa...etected which signal the presence of lung cancer, ...
..., Pa., Oct. 25 Genaera,Corporation (Nasdaq: GENR...s,related to the successful first Phase 1 study of...anding the support for selectivity and,specificity...American,Association for the Study of Obesity (NAA...ults from Study MSI-1436C-101 presented at Genaera...
Other Medicine Technology:Potential Early Warning System for Lung Cancer Identified 2Potential Early Warning System for Lung Cancer Identified 3Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 4Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 5Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 6
Seattle Small Joint Arthroscopy Cup Currette
ECTRA II System without Endoscope
ECTRA II System 25 mm
AZTEC Shoulder Holder and MITT
Medicine Products: